KARA ROBERTSON: Open Payments
NPI 1437580453 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 26 payments from 12 companies in 2025. Trend: 2023 $3,489 · 2024 $2,636 · 2025 $991
Food & beverage: $922Education: $69
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 5 | $274 |
| ABBVIE INC. | 5 | $229 |
| Novartis Pharmaceuticals Corporation | 2 | $116 |
| UCB, Inc. | 3 | $105 |
| Janssen Biotech, Inc. | 2 | $91 |
| E.R. Squibb & Sons, L.L.C. | 1 | $54 |
| Ionis Pharmaceuticals, Inc. | 1 | $37 |
| Incyte Corporation | 1 | $20 |
| GENZYME CORPORATION | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: NEMLUVIO, SKYRIZI, Bimzelx, TREMFYA, COSENTYX, Sotyktu, BOTOX, RINVOQ.
Industry payments across CO — which companies pay providers there.
